Amgen Inc is a biotechnology company that discovers, develops, manufactures and delivers human therapeutics. The Company\'s business segment is human therapeutics.
| Website: | www.amgen.com |
| Email: | investor.relations@amgen.com |
| Main Phone: | +1 805 447-1000 |
| Address: | One Amgen Center Drive |
| State: | CA |
| City / Town: | Thousand Oaks |
| Country: | USA |
| Postal Code: | 91320-1799 |
| Exchange: | NGS |
| Employees: | 17900 |
| NAICS: | Biological Produ |
| Last Price 175.89 | Change $ -5. | Change % -2.76 | Tick N/A |
| Bid 175.02 | Bid Size 100.00 | Ask 175.88 | Ask Size 100.00 |
| Open 176.01 | High 178.86 | Low 175.20 | Prev Close 180.89 |
| Last Trade | Volume 5.4 mi | 52 Wk Hi 184.21 | 52 Wk Low 133.64 |
| Market Cap 129.3 bi | Ex-Div Date | Div Rate 4.60 | Yield 2.6150 |
| Shares 735,399,128.00 | EPS (TTM) 10.55 | PE Ratio 17.10 | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 5 | 98 |
| Number of Buys | 0 | 41 |
| Number of Sells | 5 | 57 |
| Net Activity | -19761 | 128447 |
| Last 10 Buys | Shares |
|---|---|
| Fred Hassan | 1,000 |
| Fred Hassan | 1,000 |
| Frank C. Herringer | 1,000 |
| Frank C. Herringer | 1,000 |
| Robert A. Bradway | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Annette L. Such | 1,000 |
| Madhu Balachandran | 1,000 |
| Sean Harper | 1,000 |
| David Baltimore | 1,000 |
| Robert A. Bradway | 1,000 |
| De Francois Carbonnel | 1,000 |
| Judith C. Pelham | 1,000 |
| Cynthia M. Patton | 1,000 |
| Madhu Balachandran | 1,000 |
| Madhu Balachandran | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 201 | 201 | 201 | 201 |
| Low Target Price Estimate | 157 | 157 | 157 | 157 |
| Mean Target Price Estimate | 184.91 | 184 | 184 | 184.91 |
| Standard Deviation | 14.63 | 14.3 | 14.3 | 14.63 |
| Date of Most Recent Estimate | 08/02/16 | 08/02/16 | 07/28/16 | 08/19/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 67 | 2016-08-19 |
| 424B2 | Prospectus filed under Rule 424(b)(2) | 71 | 2016-08-11 |
| FWP | Free Writing Prospectus | 4 | 2016-08-11 |
| 424B3 | Prospectus filed under Rule 424(b)(3) | 70 | 2016-08-10 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-04 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2016-08-04 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-03 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-03 |
| SC 13G | Statement of beneficial ownership of common stock by certain persons | 5 | 2016-08-02 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 50 | 2016-07-29 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 |
| Moderate Buy | 1 | 2 | 2 | 2 |
| Hold | 9 | 10 | 9 | 9 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 2.32 | 2.34 | 2.3 | 2.3 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
